In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth. The ...

Scientists in China have found a new potential drug target for weight loss. Blocking a protein called CD44 has been shown to protect against obesity in mice on a high-fat diet, specifically by ...

Mice genetically engineered to lack the ability to make the amino acid cysteine, and fed a cysteine-free diet, lost 30 percent of their body weight in just one week, a new study shows. Published ...

GLP-1 drugs like Eli Lilly's Zepbound and Novo Nordisk's Wegovy work to address obesity—as long as a patient keeps taking them. Harith Rajagopalan, M.D., Ph.D. thinks his company, Fractyl Health, may ...

Researchers at Washington University School of Medicine in St. Louis have identified a novel way brown fat—an energy-burning form of fat—can rev the body's metabolic engine, consuming cellular fuel ...